Replies to post #224826 on Bioelectronics Corp (BIEL)

[Steve43]

That’s a novel idea, take advantage of the opportunity. We have never done that, why would we want too change? Hello darkness, smile old friend. Maybe that S&G tune will move the pps, a very cryptic message. JMHO Have a great morning

[markjohn62]

You are right, a total wasted opportunity. Just like the mother of all wasted opportunities, the opioid crisis. Then we have the wasted opportunities of 5 FDA clearances with the 2 mega clearances of Post surgical and musculoskeletal pain. A complete cluster F@$#.

[speakhim]

Drugstores are buying “essential” items deemed by insurance companies and things said to treat virus. Since everyone’s sales are down they are leveraging what makes them profit most. Giving space to a new product in an emergency economy is difficult to navigate. to promote a new product as the patch is not as easy.

[srinsocal]

If it were on the shelves of stores ActiPatch would still need to advertise to educate consumers on the benefits of Non-Drug Pain Relief.

Consumers would keep on buying that same old $6.99 bottle of Advil or Tylenol rather than spend the $29 for ActiPatch unless a compelling message for change was delivered.

How does BIEL fund a Nationwide Marketing Campaign for the US? Who would loan BIEL the tens of millions of dollars needed to advertise to 326 million Americans?

This is why being an OEM Supplier makes so much sense for BIEL right now. BIEL supplies devices in bulk to be incorporated into an Established Brand's Products. The OEM Partner handles all the processes that currently eat away at BIEL's Profits:

Packaging materials and labor

Distribution costs

Retailer markup

Advertising costs

Customer Support costs

The OEM Partner, being a recognized brand, has an easier path to convincing consumers of the benefits of SWT. This also helps BIEL gain consumer confidence and acceptance in its non-OEM marketing of ActiPatch.